| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.004 | 1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |